Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Besteman, E. G.
Right arrow Articles by Holladay, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Besteman, E. G.
Right arrow Articles by Holladay, S. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Diethylstilbestrol (DES)-Induced Fetal Thymic Atrophy in C57BL/6 Mice: Inhibited Thymocyte Differentiation and Increased Apoptotic Cell Death

Elizabeth G. Besteman
Kurt L. Zimmerman
Steven D. Holladay

Virginia Tech, College of Veterinary Medicine, Blacksburg, Virginia, USA

Correspondence: Address correspondence to Elizabeth G. Besteman, Virginia Tech. College of Veterinary Medicine, Duckpond Drive, Blacksburg, VA 24061-0442, USA. E-mail:ebestema{at}vt.edu

Treatment of pregnant C57Bl/6 mice with 48 µg/kg diethylstilbestrol (DES) on gestation days (GDs) 14 and 16 resulted in both decreased day 18 fetal thymic cellularity as well as alterations in thymocyte phenotype. Histopathologic examination of GD 18 fetal thymi from DES-exposed dams demonstrated a decrease in thymic size and cellularity and an increase in pyknotic nuclei, indicative of apoptosis, relative to control thymi. Thymic architecture was also altered by DES treatment with a decrease in the distinction between the cortical and medullary regions. Flow cytometric staining of day 18 thymocyte suspensions with the apoptotic marker 7-aminoactinomycin D showed a decrease in thymocyte viability after DES, and a concomitant increase of thymocytes in early apoptosis. When thymocytes were co-identified by CD4 and CD8 cell surface antigen expression, trends toward increased apoptosis were present in the CD4+CD8+ and CD4+CD8– subpopulations, and significantly increased apoptosis occurred in the CD4–CD8–and CD4–CD8+ subpopulations. These histopathologic and flow cytometric findings support enhanced apoptosis of thymocytes as a contributing factor to fetal thymic atrophy caused by DES.

Key Words: DES • Developmental • Immune • Murine • Thymus

International Journal of Toxicology, Vol. 24, No. 4, 231-239 (2005)
DOI: 10.1080/10915810591000703
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
D. A. Weinstein, R. M. Gogal Jr, A. Mustafa, M. R. Prater, and S. D. Holladay
Mid-gestation Exposure of C57BL/6 Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Postnatal Morphologic Changes in the Spleen and Liver
Toxicol Pathol, July 1, 2008; 36(5): 705 - 713.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
L. A. Burns-Naas, K. L. Hastings, G. S. Ladics, S. L. Makris, G. A. Parker, and M. P. Holsapple
What's So Special about the Developing Immune System?
International Journal of Toxicology, March 1, 2008; 27(2): 223 - 254.
[Abstract] [Full Text] [PDF]